SHP-1 Regulates STAT6 Phosphorylation and IL-4-mediated Function in a Cell Type-Specific Manner

Zan Huang,John M. Coleman,Yan Su,Meredith Mann,John Ryan,Leonard D. Shultz,Hua Huang

DOI: https://doi.org/10.1016/j.cyto.2004.10.004

IF: 3.926

2005-01-01

Cytokine

Abstract:SHP-1 has been shown to play positive and negative regulatory roles in IL-4-induced STAT6 phosphorylation and in IL-4-mediated functions. To determine whether SHP-1 can regulate STAT6 phosphorylation and IL-4-mediated functions in a cell type-specific manner in the immune system, we examined the IL-4 receptor (IL-4R) expression, STAT6 phosphorylation, and IL-4-mediated functions in CD4+ and CD8+ T cells of viable motheaten (mev/mev) and littermate control (+/−) mice. CD4+ T cells as well as CD8+ T cells from the lymph node of mev/mev and +/− mice expressed comparable levels of IL-4R. In CD4+ T cells, the loss of SHP-1 activity did not affect IL-4-induced STAT6 phosphorylation or IL-4-mediated function. In contrast, SHP-1-deficient CD8+ T cells from mev/mev mice failed to develop into IL-4-producing type-2 cytotoxic T cells (Tc2) in the presence of IL-4 despite that they showed comparable levels of STAT6 phosphorylation to that of +/− CD8+ T cells. Loss of SHP-1 activity also abolished IL-4-mediated inhibition of c-kit expression in bone marrow-derived mast cell (BMMC). Thus, our data suggest that SHP-1 may regulate IL-4-induced STAT6 phosphorylation and IL-4-mediated functions in a cell type-specific manner.